Roivant Sciences Ltd.

NASDAQ (USD): Roivant Sciences Ltd. (ROIV)

Last Price

12.00

Today's Change

0.00 (0.00%)

Day's Change

11.88 - 12.06

Trading Volume

3,210,417

Overview

Market Cap

8 Billion

Shares Outstanding

727 Million

Avg Volume

4,728,772

Avg Price (50 Days)

11.89

Avg Price (200 Days)

11.31

PE Ratio

2.17

EPS

5.54

Earnings Announcement

11-Feb-2025

Previous Close

12.00

Open

11.98

Day's Range

11.88 - 12.065

Year Range

9.69 - 13.055

Trading Volume

3,298,276

Price Change Highlight

1 Day Change

0.00%

5 Day Change

4.62%

1 Month Change

-5.51%

3 Month Change

3.72%

6 Month Change

13.53%

Ytd Change

5.73%

1 Year Change

4.62%

3 Year Change

1.52%

5 Year Change

15.38%

10 Year Change

15.38%

Max Change

15.38%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment